Neutrophil depletion improves diet-induced non-alcoholic fatty liver disease in mice
- PMID: 28508193
- DOI: 10.1007/s12020-017-1323-4
Neutrophil depletion improves diet-induced non-alcoholic fatty liver disease in mice
Abstract
Purpose: Non-alcoholic fatty liver disease is highly associated with morbidity and mortality in population. Although studies have already demonstrated that the immune response plays a pivotal role in the development of non-alcoholic fatty liver disease, the comprehensive regulation is unclear. Therefore, present study was carried out to investigate the non-alcoholic fatty liver disease development under neutrophil depletion.
Methods: To achieve the aim of the study, C57BL/6 J mice were fed with high fat diet for 6 weeks before treated with neutrophil deplete antibody 1A8 or isotype control (200 μg/ mouse every week) for another 4 weeks.
Results: Treated with 1A8 antibody, obese mice exhibited better whole body metabolic parameters, including reduction of body weight gain and fasting blood glucose levels. Neutrophil depletion also effectively reduced hepatic structural disorders, dysfunction and lipid accumulation. Lipid β-oxidative markers, phosphorylated-AMP-activated protein kinase α and phosphorylated-acetyl-CoA carboxylase levels were increased in 1A8 antibody-treated obese mouse group. The mitochondrial number and function were also reversed after 1A8 antibody treatment, including increased mitochondrial number, reduced lipid oxidative damage and enhanced mitochondrial activity. Furthermore, the expression of inflammatory cytokines, tumor necrosis factor-α, interleukin-6, and monocyte chemoattractant protein-1 were obviously reduced after neutrophil depletion, accompanied with decreased F4/80 mRNA level and macrophage percentage in liver. The decreased NF-κB signaling activity was also involved in the beneficial effect of neutrophil depletion.
Conclusion: Taken together, neutrophil depletion could attenuate metabolic syndromes and hepatic dysfunction.
Keywords: Inflammation; Lipid β-oxidation; Mitochondria; Neutrophil; Non-alcoholic fatty liver disease.
Similar articles
-
Green tea polyphenols ameliorate non-alcoholic fatty liver disease through upregulating AMPK activation in high fat fed Zucker fatty rats.World J Gastroenterol. 2017 Jun 7;23(21):3805-3814. doi: 10.3748/wjg.v23.i21.3805. World J Gastroenterol. 2017. PMID: 28638220 Free PMC article.
-
Wheat-bran autolytic peptides containing a branched-chain amino acid attenuate non-alcoholic steatohepatitis via the suppression of oxidative stress and the upregulation of AMPK/ACC in high-fat diet-fed mice.Int J Mol Med. 2017 Feb;39(2):407-414. doi: 10.3892/ijmm.2016.2831. Epub 2016 Dec 14. Int J Mol Med. 2017. PMID: 28000843
-
Adzuki bean ameliorates hepatic lipogenesis and proinflammatory mediator expression in mice fed a high-cholesterol and high-fat diet to induce nonalcoholic fatty liver disease.Nutr Res. 2016 Jan;36(1):90-100. doi: 10.1016/j.nutres.2015.11.002. Epub 2015 Nov 10. Nutr Res. 2016. PMID: 26773785
-
Critical Role of NFκB in the Pathogenesis of Non-alcoholic Fatty Liver Disease: A Widespread Key Regulator.Curr Mol Med. 2021;21(6):495-505. doi: 10.2174/1566524020666201026162343. Curr Mol Med. 2021. PMID: 33106141 Review.
-
Inflammation in Alcoholic and Nonalcoholic Fatty Liver Disease: Friend or Foe?Gastroenterology. 2016 Jun;150(8):1704-9. doi: 10.1053/j.gastro.2016.01.025. Epub 2016 Jan 27. Gastroenterology. 2016. PMID: 26826669 Free PMC article. Review. No abstract available.
Cited by
-
Neutrophils: tissue and circulating signatures of pediatric non-alcoholic fatty liver disease.Front Cell Dev Biol. 2024 Jan 4;11:1336033. doi: 10.3389/fcell.2023.1336033. eCollection 2023. Front Cell Dev Biol. 2024. PMID: 38239291 Free PMC article. Review.
-
Mitochondrial Dysfunction in Metabolic Dysfunction Fatty Liver Disease (MAFLD).Int J Mol Sci. 2023 Dec 15;24(24):17514. doi: 10.3390/ijms242417514. Int J Mol Sci. 2023. PMID: 38139341 Free PMC article. Review.
-
A high-trans fat, high-carbohydrate, high-cholesterol, high-cholate diet-induced nonalcoholic steatohepatitis mouse model and its hepatic immune response.Nutr Metab (Lond). 2023 May 27;20(1):28. doi: 10.1186/s12986-023-00749-w. Nutr Metab (Lond). 2023. PMID: 37244987 Free PMC article.
-
Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment.Nat Rev Gastroenterol Hepatol. 2023 Aug;20(8):487-503. doi: 10.1038/s41575-023-00754-7. Epub 2023 Mar 17. Nat Rev Gastroenterol Hepatol. 2023. PMID: 36932227 Review.
-
Overview of Cellular and Soluble Mediators in Systemic Inflammation Associated with Non-Alcoholic Fatty Liver Disease.Int J Mol Sci. 2023 Jan 24;24(3):2313. doi: 10.3390/ijms24032313. Int J Mol Sci. 2023. PMID: 36768637 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
